Pectolinarin is a disaccharide derivative that consists of pectolinarigenin substituted by a 6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl moiety at position 7 via a glycosidic linkage.
Definition
US FDA substance register · UNII BY44L9O1RR · registered name PECTOLINAROSIDE · single chemical substance
Pectolinarin is a disaccharide derivative that consists of pectolinarigenin substituted by a 6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl moiety at position 7 via a glycosidic linkage. It has a role as an EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor, an antioxidant, an antineoplastic agent, an anti-inflammatory agent, an apoptosis inducer and a plant metabolite. It is a dimethoxyflavone, a rutinoside, a monohydroxyflavanone, a glycosyloxyflavone and a disaccharide derivative. It is functionally related to a pectolinarigenin.
Source: PubChem
Pectolinarin is the organic compound that conforms to the formula.
Cosmetic roles
More data — names, identifiers, properties, test records, literature
Names & identifiers
- CAS No.chemical registry number
- 28978-02-1
- DTXSIDUS EPA chemical ID
- DTXSID70951590
- DTXCIDUS EPA compound ID
- DTXCID701379704
- IUPAC
- 5-Hydroxy-6-methoxy-2-(4-methoxyphenyl)-4-oxo-4H-1-benzopyran-7-yl 6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside
- Molecular formula
- C29H34O15
- Molecular weight
- 622.576 g/mol
What products actually use it for
What the 2 products reported to the US EPA with this ingredient use it for. Products outside cosmetics are included, so the top few rows are its main uses.
- Antioxidant1
- Softener and conditioner1
Source: US EPA CompTox dashboard
Related literature
- Temperature‐sensitive hydrogel releasing pectolinarin facilitate scarless wound healing · 2024
- Identification and Quantification of Bioactive Molecules Inhibiting Pro-inflammatory Cytokine Production in Spent Coffee Grounds Using Metabolomics Analyses · 2020
- Glycosyl flavonoid profile, in vivo antidiabetic and in vitro antioxidant properties of Linaria reflexa Desf. · 2017
- Differential effect of flavonoids on glycosaminoglycan content and distribution in skin fibroblasts of patients with type I osteogenesis imperfecta. · 2010